Join
Live feed
·
INSIDERFilingvia Quantisnow
Checkpoint Therapeutics Inc. logo

Large owner Fortress Biotech, Inc. sold $129,000 worth of shares (100,000 units at $1.29) and returned $25,101,221 worth of shares to the company (6,122,249 units at $4.10), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CKPT (Checkpoint Therapeutics Inc.) and more on Quantisnow.